The Patent Finder

Biorealites, S.A.S.

Also on record
Records under this name other than patents Biorealites, S.A.S. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Biorealites, S.A.S.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,611,320Monoclonal Antibodies to Progastrin and Their Uses
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,487,582Methods for Treating Pancreatic Cancer
Formerly held
Lapsed on the fee record
Ended Nov 8, 2024 · High confidence
Lapsed on the fee recordEnded Nov 8, 2024High confidence
US 10,533,050Methods and Compositions for Liver Cancer Therapy
Formerly held
Lapsed on the fee record
Ended Jan 14, 2024 · High confidence
Lapsed on the fee recordEnded Jan 14, 2024High confidence
US 9,217,032Methods for Treating Colorectal Cancer
Formerly held
Lapsed on the fee record
Ended Dec 22, 2023 · High confidence
Lapsed on the fee recordEnded Dec 22, 2023High confidence
US 8,900,588Methods for Treating Breast Cancer
Formerly held
Lapsed on the fee record
Ended Dec 2, 2022 · High confidence
Lapsed on the fee recordEnded Dec 2, 2022High confidence
US 8,900,817Progastrin and Liver Pathologies
Formerly held
Lapsed on the fee record
Ended Dec 2, 2022 · High confidence
Lapsed on the fee recordEnded Dec 2, 2022High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited